Formulations and their use in the treatment of neurological diseases

  • US 5,540,938 A
  • Filed: 10/24/1994
  • Issued: 07/30/1996
  • Est. Priority Date: 11/02/1990
  • Status: Expired due to Term
First Claim
Patent Images

1. A method for the treatment of a neurological disease where the disease is characterised by a slowing of nerve impulse transmission, which comprises administering to a patient in need thereof a medicament containing a mono- or di-aminopyridine active agent, said medicament being effective to permit sustained release of said mono- or di-aminopyridine active agent at a rate allowing controlled absorption thereof which achieves therapeutically effective blood levels over a 12-24 hour period when administered on a once- or twice-daily basis.

View all claims
  • 6 Assignments
Timeline View
Assignment View